Criterium Blog FDA Approves Trastuzumab Deruxtecan for Any HER2-Positive Solid Cancer

The drug trastuzumab deruxtecan (Enhertu) can now be used to treat a wide variety of cancers, thanks to a new approval from the Food and Drug Administration (FDA). The post FDA Approves Trastuzumab Deruxtecan for Any HER2-Positive Solid Cancer appeared first on Criterium.